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Electrolyte imbalanceAbstract Background: Electrolyte disturbances have been reported in both tuberculosis (TB)
infection alone and TB-HIV co-infected patients.
Objectives: To evaluate the effects of treatments on the imbalance of some electrolytes among
patients infected with Mycobacterium tuberculosis in Osogbo Southwestern Nigeria.
Methodology: A total of one hundred and ten patients participated in this study. They were divided
into four groups as follows: group 1 contains 50 normal patients without TB or HIV infec-
tion (M = 25; F = 25), group 2 20 new positive cases of TB patients without HIV infection
(M = 13; F = 07), group 3 20 new positive cases of tuberculosis co-infected with HIV infec-
tion (M = 10; F = 10), and group 4 20 positive cases of TB patients on anti tuberculous drugs
(M = 11; F = 09). All patients were screened for the presence and absence of TB, HIV and the level
of some electrolytes in plasma (sodium, potassium, chloride and bicarbonates) were determined
using standard methods.
Results: Levels of sodium in TB patients on drugs (TBD) were significantly lowered compared to
new case tuberculosis (NCT) patients (134.80 ± 5.83 mmol/L vs 142.10 ± 6.68 mmol/L) while
potassium levels were significantly elevated in TB patients on drugs compared with their new case
counterparts (3.75 ± 0.15 mmol/L vs 3.07 ± 0.42 mmol/L) P < 0.05 respectively. Chloride levels
256 A.W. Olalekan et al.were significantly decreased in TB patients on treatment compared to new case tuberculosis NCT
(99.26 ± 6.85 mmol/L vs 108.76 ± 8.42 mmol/L) while serum bicarbonate levels were significantly
elevated in TB patients on drug (TBD) compared to their NCT counterparts (24.00 ± 1.81 mmol/L
vs 21.00 ± 2.05 mmol/L, P< 0.05, respectively).
Conclusion: Hyponatraemia, hyperkalaemia, and hypochloremia characterized some of the elec-
trolyte imbalance among TB patients receiving treatments. The raised level of bicarbonate may
be attributed to overcorrection of respiratory acidosis often found in patients with tuberculosis.
Monitoring electrolytes is therefore an important component of TB management.
ª 2014 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/3.0/).1. Introduction
Tuberculosis is a major cause of morbidity, disability and
death.1 It accounts for 2–3 million deaths per annum, global-
ly.1,2 One third of the World population has been exposed to
the TB bacterium, and new infections occur at a rate of one
per second.3 In 2006, a total of 1.7 million people died of TB
including 231,000 people with HIV.3 Nigeria has the fourth
highest burden of Tuberculosis (TB) in the world, with an annu-
al incidence of 311 cases per 100,000 population and a mortality
rate of 81 per 100,000 population in 2006.4 In Nigeria, about
21% of all TB patients are dually infected with TB and HIV.4,5
Factors contributing to the resurgence of tuberculosis in
developing countries include co-infection with HIV; emergence
of multiple resistant tuberculosis, inadequate treatment, pover-
ty, malnutrition, overcrowding, armed conflict and increasing
numbers of displaced persons. diarrhea, vomiting, and exces-
sive sweating, are common features of HIV/AIDS and Tuber-
culosis infections and have been described as possible cause of
loss of water and electrolyte. However, reports showed that the
frequency and nature of renal and electrolyte abnormalities in
HIV patients vary considerably from centre to centre.6 Fluid-
electrolyte and acid-base derangements frequently encountered
in AIDS and TB, have been found to be major factors for the
development of acute renal failure.7
In view of this associated water and electrolyte derange-
ment and associated cytochemical changes in Tuberculosis
and HIV infections, this study was designed to determine the
effect of treatment on common electrolytes and free radical
status in patients with tuberculosis and those with co-infection
with HIV. Comparing electrolyte values in controls with pul-
monary tuberculosis patients not on treatment, comparing
electrolyte values in controls with pulmonary tuberculosis
patients on treatment, and electrolyte in pulmonary tuberculo-
sis patient on treatment with those not on treatment could all
contribute to the body of knowledge on electrolyte distur-
bances associated with these diseases. The overall objectives
of this study are to evaluate the effects of treatments on the
imbalance of some electrolytes among patients infected with
Mycobacterium tuberculosis in Osogbo Southwestern Nigeria
2. Methods
2.1. Study location
The study location was Osogbo, the capital city of Osun State.
With a population of about half a million, HIV prevalence of25% was reported among TB positive in 2010, though HIV
prevalence in the state was a bit lower than the national aver-
age of 4.1.8 There are numerous health facilities providing care
at different levels of health care. There are two non govern-
mental organizations whose presence could be felt in the areas
of HIV and TB in the city.
2.2. Study design
Descriptive cross sectional study among various categories of
TB infected patients.
2.3. Study population
Include 4 categories of patients, recruited from four TB man-
agement centres in Osogbo. The categories are
(a) Group 1: 50 normal patients without TB or HIV in the
sex ratio of 1:1.
(b) Group 2: 20 new positive cases of M. tuberculosis
patients without HIV in the ratio of M:F of 2:1.
(c) Group 3: 20 new positive cases of tuberculosis co-infect-
ed with HIV in a sex ratio of 1:1.
(d) Group 4: 20 positive cases of M. tuberculosis patients on
anti tuberculous drugs with 11 males and 09 females.
2.4. Exclusion criteria
Patients with symptoms of malaria fever, Diabetes Mellitus,
severe malnutrition, patients with intestinal infection which
could lead to dysentery, women using contraceptives, patients
on corticosteroid therapy, pregnant women and patients with
symptoms of jaundice were excluded from this study.
2.5. Ethical approval
The study received approval of the ethics review committee of
LAUTECH Teaching Hospital Osogbo. Written informed
consent was obtained from each subject after the study has
been explained to them.
2.6. Sampling procedure
Two Primary Health Care (PHC) centers were randomly
selected from the list of primary health facilities to complement
Figure 1 Frequency and percentage distribution of the study
participants.
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evolved Sabo Primary Health Centre, Oke-Baale Primary
Health Centre, General hospital Asubiaro and Ladoke Akin-
tola University of Technology Teaching Hospital, Osogbo. A
total of one hundred and ten patients were serially recruited
to participate in this study. Every new case was screened for
M. tuberculosis (in their sputum using Ziehl-Neelsen modified
technique). The presence or absence of HIV in their blood was
carried out using the National algorithm for the diagnosis of
HIV (Determine-Unigold-Start-pack Kits). Fifty (50) controls
for this study were recruited among volunteers who were on
routine medical check-up at the teaching hospital. These were
matched for age with the cases. They were also screened for
HIV and pulmonary TB and confirmed negative.
2.7. Treatments
After their tuberculosis was diagnosed, patients were com-
menced on Anti TB drugs of DOTS (Directly Observed Treat-
ment– Short course) according to National guidelines on
treatment of TB, and TB and HIV co-infection.9 All cases were
managed by the attending TB officer while TB-HIV co-infect-
ed patients attend both TB and ART (antiretroviral therapy)
clinics. AntiTB drugs were administered by the health care
workers in the facility.
2.8. Blood and sputum sample collection
Five to seven millimeters of venous blood was obtained from
the cubital vein of each patient using a sterile needle and syr-
inge into a lithium heparin bottle. The plasma was extracted
by centrifugation for 10 min at 4000 rpm into a plain bottle
and stored at 20 C until the time of analysis for electrolytes
and free radicals. The sputum of patients (except those on anti-
tuberculosis drugs) and controls were collected into a sterile
universal bottle for Ziehl-Neelsen staining.
3. Biochemical analysis
Estimation of sodium and potassium using Flame emission spec-
trophotometry method. Atom of metals in the hot flame gained
sufficient energy thereby making a specific amount of quantum
of thermal energy to be absorbed by an orbital electron. The
electrons being unstable in this high energy (excited) state release
their excess energy as photons at a particular wavelength as they
change from excited state to their previous or ground state.10
Estimation of chloride using colorimetric: TPTZ [mer-
cury(II)-2,4,6-tri-(2-pyridyl)-s-triazine] method. This was
based on the principle that Chloride ions react with a
mercury(II)-2,4,6-tri-(2-pyridyl)-s-triazine (TPTZ) complex to
form mercury(II) Chloride. The librated TPTZ react with
Iron (II) ions yielding a blue coloured complex. The resulting
absorbance change at 590 nm is directly proportional to the
amount of chloride ion in the sample.11
Estimation of bicarbonate using back titration method. This
was based on the principle that: When a known volume of a
standard HCl is added to HCO3 present in the plasma, there
will be a reaction between HCl and HCO3 resulting in the pro-
duction of carbon dioxide gas. The excess HCl that is not used
up is back titrated with a standard solution of NaOH to an end
point. The reaction mixture must be thoroughly shaken.124. Results
Fig. 1 is a pie chart showing the frequency and percentage dis-
tribution of the study population. The test group comprises
three (3) sub-groups; first group are the new cases and made
up of 20 patients (18.18% of the total population) who are
not on drugs. The second group are those on drugs for 5–
6 weeks and also made up of 20 patients (18.18% of the total
population) while the third group are those having co-infection
with HIV. They are also made up 20 patients and not on drugs
(18.18% of the total population). The control groups are 50
patients (45.45% of the total population).
4.1. Physical parameters
In Table 1, the mean age and mean height for all the patients
was not significantly different from those of the control
patients. There was a significant decrease in weight (in kilo-
grams) when TB-co-infection with HIV patients was compared
with new cases of Tuberculosis and TB patients on drugs
(43.83 ± 7.58 vs 52.78 ± 15.10, 50.75 ± 12.47; P < 0.05).
There was no significant difference in the weight when new
cases of tuberculosis were compared with TB patients on drugs
(P> 0.05).
4.2. Biochemical parameters
In Table 1, the sodium value was significantly lower in controls
when compared with the total subject population, new case TB
patients and TB co-infection with HIV patients (135.46 ± 4.00
vs 139.15 ± 7.50 vs 142.10 ± 6.68, 140.55 ± 8.07) mmol/L
There was a significant increase in mean sodium value when
TB co-infection with HIV patients were compared with TB
patients on drugs (140.55 ± 8.07 vs 134.80 ± 5.83 mmol/L;
P < 0.05), Table 1.
Potassium value was significantly lower in controls when
compared with total subject population, TB patients on drugs
and TB co-infection with HIV subject (3.17 ± 0.31 vs
3.50 ± 0.48, 3.75 ± 0.15, 3.66 ± 0.42 mmol/L; P < 0.05).
However, there was a significant decrease in potassium value
of new case TB patients when compared with control
(3.07 ± 0.42 vs 3.17 ± 0.31 mmol/L; P < 0.05).
Similarly, there was a significant decrease in mean potassi-
um value when new case TB patients were compared with TB
Table 1 Comparing parameters in Control patients with cases (TB new cases, TB cases on drug, TB cases co-infection with HIV).
Parameter Controls
n= 50 M± SD
New cases
n= 20 M± SD
t-Value P-Value TB on drugs
n= 20 M± SD
t-Value P-Value TB-HIV
n = 20 M± SD
t-Value P-Value
Age (y) 35.56 ± 11.19 35.15 ± 12.12 1.13 0.26 34.38 ± 11.98 0.39 0.71 39.10 ± 10.10 1.23 0.21
Weight (kg) 52.00 ± 9.50 52.78 ± 15.10 0.30 0.76 50.75 ± 12.47 0.42 0.20 43.83 ± 7.58 3.39 0.04
Height (m) 1.66 ± 0.13 1.67 ± 0.15 0.26 0.78 1.62 ± 0.14 1.29 0.68 1.59 ± 0.79 2.64 0.66
Na+ mmol/l 135.46 ± 4.00 142.10 ± 6.68 5.13 0.00 134.80 ± 5.83 0.55 0.58 140.55 ± 8.07 3.53 0.01
K+ mmol/l 3.17 ± 0.31 3.07 ± 0.42 4.78 0.01 3.75 ± 0.15 7.97 0.00 3.66 ± 0.42 5.40 0.00
Cl mmol/l 101.52 ± 4.40 108.76 ± 8.42 0.44 0.01 99.26 ± 6.85 1.67 0.98 104.81 ± 8.08 2.19 0.32
HCO3
 mmol/l 21.64 ± 1.47 21.00 ± 2.05 1.47 0.22 24.00 ± 1.81 5.68 0.00 24.40 ± 1.64 6.68 0.00
258 A.W. Olalekan et al.patients on drugs and TB co-infection with HIV (3.07 ± 0.42
vs 3.75 ± 0.15, 3.66 ± 0.42 mmol/L; P < 0.05). There was no
significant difference between TB patients on drug and TB
co-infection with HIV (3.75 ± 0.15 vs 3.66 ± 0.42) mmol/L.
There was no significant difference observed between the
total subject population and control (104.27 ± 8.56 vs
101.52 ± 4.40) mmol/L. There was a significantly higher mean
value of chloride in new case of TB patients when compared
with control (108.76 ± 8.42 vs 101.52 ± 4.40 mmol/L;
P < 0.05) as well as highly significant mean value of chloride
in control when compared with TB patients on drugs
(101.52 ± 4.40 vs 99.26 ± 6.85 mmol/L; P < 0.05).
However, the mean value of chloride was significantly high-
er in new case TB patients when compared with TB patients on
drug and TB co-infection with HIV (108.76 ± 8.42 vs
99.26 ± 6.85, 104.81 ± 8.08 mmol/L; P < 0.05). The mean
chloride value was also significantly higher in TB co-infection
with HIV when compared with TB patients on drugs
(104.81 ± 8.08 vs 99.26 ± 6.8) mmol/L; P < 0.05).
However, there was no significance difference in mean
bicarbonate value when new case TB patients were comparedTable 2 Pearson’s correlation table of tuberculosis patients on dru
Variable Age (y) Height (m) Weight (kg) Na+ (
Age (y) 1 .433 .434 .036
Height (m) .433 1 .828* .281
Weight (kg) .434 .828** 1 .011
Na+ (mmol/L) .036 .281 .011 1
K+ (mmol/L) .191 .126 .224 .224
Cl (mmol/L) .045 .318 .005 .970**
HCO3
(mmol/L) .011 .208 .028 .690**
* Correlation is significant at 0.05 level (2-tailed).
** Correlation is significant at 0.01 level (2-tailed).
Table 3 Pearson’s correlation table of tuberculosis co-infection wit
Variable Age (y) Height (m) Weight (kg) Na+ (
Age (y) 1 .034 .045 .123
Height (m) .034 1 .157 .060
Weight (kg) .045 .157 1 .261
Na+ (mmol/L) .123 .060 .261 1
K+ (mmol/L) .271 .300 .334 .793**
Cl (mmol/L) .110 .060 .256 .979**
HCO3
(mmol/L) .131 .519 .063 .109
* Correlation is significant at 0.05 level (2-tailed).
** Correlation is significant at 0.01 level (2-tailed).with controls (21.00 ± 2.05 vs 21.64 ± 1.47 mmol/L;
P < 0.05). The mean value of bicarbonate was significantly
lower in control when compared with total patient population,
TB patients on drug, TB co-infection with HIV patients
(21.64 ± 1.47 vs 23.13 ± 2.40, 24.00 ± 1.81,
24.40 ± 1.64 mmol/L; P < 0.05). Also, the mean value of
bicarbonate was significantly lower in new case TB patients
when compared with TB patients on drug and TB co-infection
with HIV (21.00 ± 2.05 vs 24.40 ± 1.64 mmol/L; P < 0.05).
Meanwhile, there was no significant difference between TB
patients on drugs and TB co-infection with HIV
(24.00 ± 1.81 vs 24.40 ± 1.64) mmol/L.
In Table 2, the patients on drugs show a positive correlation
between height and weight (r = 0.828, P < 0.01), sodium and
chloride (r = 0.970, P < 0.01) while an inverse correlation
was observed between sodium and bicarbonate (r= 0.690,
P < 0.01), chloride and bicarbonate (r= 0.803, P < 0.01).
In Table 3, which shows Pearson’s correlation of TB patients
co-infection with HIV a positive correlation was observed
between sodium and chloride (r= 0.979, P < 0.01), while
an inverse correlation was observed between height andgs.
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(r= 0.763, P < 0.01), potassium and sodium (r = 0.793,
P < 0.01) and potassium and free radicals (r = 0.478,
P < 0.05).
5. Discussion
The mean lower level of sodium Na+ found in TB co infec-
tions with HIV patients than the new cases pulmonary tuber-
culosis patients, is consistent with another study.13 This can
be attributed to the loss of Na+ through diarrhoea presented
by most of AIDs infected patients.13,14 At the same time,
decreased Na+ observed in patients on drug than control
patients, and those patients on drugs than new cases pul-
monary TB patients, and TB co infections with HIV patients
could be due to the fact, that loss of water and salt leads to
dehydration.14 These are consistent with findings from this
study in which 14 (70%) of patients taking drug experience
vomiting. This is one of the major adverse reactions of some
antiTB drugs especially Pyrazinamide.15
The observed significant higher mean values of Sodium
Na+ level in the total patients than in control may be attribu-
table to dehydration due to vomiting, muscle wasting, fever
and because sweat is hypotonic compared with plasma.16
The same reason for the above can also hold for higher sig-
nificant values of Na+ in new case tuberculosis patients, TB
Co infection with HIV when compared with controls.
It was found that the mean K+ level in patients with TB co
infections with HIV patients was significantly higher than
those of the new cases pulmonary tuberculosis patients and
the control patients. The above observation can be attributed
to the facts that in HIV/AIDS infection, there is the killing
of cells by virus, high grade pyrexia/fever (causing the destruc-
tion of cells) and therefore leading to the influx of K+ from the
cells to the plasma.17 The mean K+ value of patients on drug
was significantly higher compared to other patient groups and
control; this may be due to non compliance in prescription of
drug therapy. Inappropriate administration of Rifampicin (less
often than twice weekly) may cause a flu like syndrome char-
acterized by fever and anaemia leading to hyperkalamia.18
In this study, the level of K+ was significantly lower in pul-
monary tuberculosis patients when compared to the normal
patients. This agreed with another study.19 In the stress situa-
tion due to severe/chronic illness there is increased catabolism
of protein leading to the movement of K+ from the intercellu-
lar compartment to the plasma and consequently excreted in
the urine, sweat and vomitus without any compensatory
replacement through food due to anorexia a common feature
of pulmonary tuberculosis.20
The mean value of chloride gave the same pattern as the
level of Na+ in the patients because Na+ is always (in most
cases) in association with Cl, therefore the same reason for
the level of Na+ in the patients also holds for this. The lower
significant bicarbonate level in the pulmonary tuberculosis
patients than the TB co infections and the normal patients
can be attributed to the body’s compensatory mechanism to
maintain electrochemical neutrality due to the plasma levels
of Na+ and especially chloride.16 The significantly higher level
of free radicals found in new case pulmonary tuberculosis
patients, TB co-infection with HIV can be attributed to the
facts that mycobacterium induces Reactive Oxygen Species(ROS) and nitrogen intermediates (RNI) by activating phago-
cytes,21 there by promoting tissue injury and inflammation.
This further contributes to immune-suppression,22 in HIV
infected patients23,24 with consequent production of ROS
and RNI in larger amounts.22 The inability of this study to
do a PCR or culture to differentiate between typical and aty-
pical Mycobacteria due to resource constraints could be
regarded as a limitation to this study. This could have given
a differential diagnosis with the likelihood of presenting with
similar symptoms. This is however not a main focus of this
research.
6. Conclusion
This study suggests that the institution of treatment on TB
patients seems to bring about the development of hypona-
traemia, hyperkalaemia, hypochloraemia and hypercar-
bonaemia. The raised level of bicarbonate may be attributed
to overcorrection of increased partial pressure of carbon diox-
ide (i.e., respiratory acidosis) often found in patients with
tuberculosis. Electrolyte and acid-base balance monitoring in
patients with tuberculosis is recommended once treatment is
recommenced.
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